Prevalence of pathogenic germline variants in the circulating tumor DNA testing.

Yoshihiro YamamotoKeita FukuyamaMasashi KanaiTomohiro KondoMasahiro YoshiokaTadayuki KouPham Nguyen QuyReiko Kimura-TsuchiyaTakahiro YamadaShigemi MatsumotoShinji KosugiManabu Muto

Published in: International journal of clinical oncology (2022)

Our current study demonstrated that VAFs values are helpful for selecting presumed germline variants in clinical ctDNA testing.

Keyphrases

circulating tumor
cell free
circulating tumor cells
copy number
dna repair
risk factors
gene expression
genome wide
nucleic acid